Research Article
Safety Evaluation of Turmeric Polysaccharide Extract: Assessment of Mutagenicity and Acute Oral Toxicity
Table 4
Clastogenicity study upon short term exposure (4 h) of NR-INF-02 in the presence of metabolic activation in human blood lymphocytes.
| Treatment | Vehicle control |
Positive control B[a]P (20.00 µg/mL) |
NR-INF-02 (2500.00 µg/mL) |
NR-INF-02 (791.14 µg/mL) |
NR-INF-02 (250.36 µg/mL) | R1 | R2 | R1 | R2 | R1 | R2 | R1 | R2 | R1 | R2 |
| Total number of metaphase analyzed | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | Normal | 100 | 97 | 93 | 89 | 100 | 96 | 97 | 97 | 98 | 98 | Chromatid break | — | — | 3 | 2 | — | — | — | — | — | 1 | Chromosome break | — | — | 1 | 1 | — | — | 1 | — | — | — | Deletion | — | — | — | — | — | — | 1 | — | — | — | Ring | — | — | 1 | 5 | — | 3 | — | 2 | — | — | Dicentric | — | 1 | 1 | 1 | — | — | — | 1 | 1 | 1 | Fragment | — | — | — | — | — | — | — | — | — | — | Gap | — | — | — | — | — | — | 1 | — | — | — | Ploidy | — | 2 | 1 | 2 | — | — | — | — | 1 | — | Endoreduplication | — | — | — | — | — | 1 | — | — | — | — | Total aberrations | 0 | 1 | 6 | 9 | 0 | 3 | 2 | 3 | 1 | 2 | Total aberrations (Mean ± SD) | | | | | | Mitotic Index (Mean ± SD) | | | | | |
|
|
R: replicate; 5; B[a]P: benzo[a]pyrene; Ploidy, endoreduplication, gaps, and fragments are not considered as aberrations for calculations.
|